Human Interleukin-29/Interferon Lambda 1

Product Features: 
  • Recombinant Human Interleukin-29/IFN Lambda 1 expressed in mouse myeloma cells, NS0-derived
  • Exerts antiviral activity and up-regulation of MHC class I antigen expression
  • Plays an important role in host defenses against microbes

Full Product Name: Human Interleukin-29 (IL-29)/Interferon Lambda 1  


Catalog No. Pack Size Price Quantity

≥ 1 x 105 units



Formulation Supplied lyophilized
Molecular Weight 21.4 kDa
Source Gene obtained from NSO derived mouse myeloma cells
Purity Greater than 95%
Endotoxin levels < 1 EU/ug
Bioactivity Measured using a cytopathic inhibition assay on human hepatocellular carcinoma cells (HepG2) infected with EMCV
Storage For retention of full activity store at -70°C or below and avoid repeated freeze/thaw cycles
Synonyms IL-29, IFN-λ1, IFN-lambda 1
Accession Number Q8IU54

Tech Info / Data


The IFN-lambda gene family is composed of three distinct genes: IFN-lambda 1 (IL-29), IFN-lambda 2 (IL-28A) and IFN-lambda 3 (IL-28B). All three are class II cytokine receptor ligands that are distinctly related to members of the IL-10 family and type I family.

IL-28A, IL-28B, and IL-29, also named interferon-λ2 (IFN-λ2), IFN-λ3, and IFN-λ1, respectively, are newly identified class II cytokine receptor ligands that are distantly related to members of the IL-10 family (11-13% aa sequence identity) and type I IFN family (15 - 19% aa sequence identity). The genes encoding these three cytokines are localized to chromosome 19 and each is composed of multiple exons. The exon organization of these genes is also found in the IL-10 family genes but is distinct from the type I IFNs, which are encoded within a single exon. The expression of IL-28A, B, and IL-29 is induced by virus infection or double-stranded RNA. All three cytokines exert bioactivities that overlap those of type I IFNs, including antiviral activity and up-regulation of MHC class I antigen expression. The three proteins signal through the same heterodimeric receptor complex that is composed of the IL-10 receptor β (IL-10 Rβ) and a novel IL-28 receptor α (IL-28 Rα, also known as IFN-λ R1). Ligand binding to the receptor complex induces Jak kinase activation and STAT1 and STAT2 tyrosine phosphorylation. The phosphorylated STAT1 and STAT2 complex with IFN-regulatory factor 9 (IRF-9) to form the IFN-stimulated regulatory factor 3 (ISGF-3) transcription factor complex that is translocated to the nucleus. ISGF-3 binds to the IFN-stimulated response element (ISRE) present in the regulatory regions of the target genes. Human IL-29 cDNA encodes a 200 amino acid (aa) residue precursor protein with a putative 19 aa signal peptide and a 181 aa mature protein, which is a monomer in solution. It shares 67% and 69 aa sequence identity with human IL-28A and human IL-28B, respectively.


11725-1 Human Interleukin-29/Interferon Lambda 1, human cell expressed (HCE) Titration

Related Products

Catalog No. Description Pack Size Price Quantity
11720-1 Human IL-28A/IFN Lambda 2, HCE

≥ 1 x 105 units

11730-1 Human IL-28B/IFN Lambda 3, HCE

≥ 1 x 105 units

11821-1 Human Interleukin-28A/Interferon Lambda 2, carrier-free

25 μg

11826-1 Human Interleukin-29/Interferon Lambda 1, carrier-free

25 μg


Find your product of interest by searching for category, species, molecule and/or application.

Visit our blog to read about recent developments in the fields of interferon, cytokine and biomarker research!

Sign up for our mailing list to be kept up-to-date on the latest promotions, company and product news.

Go to top